These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, Nathan DM, DCCT/EDIC Research Group. Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271 [Abstract] [Full Text] [Related]
3. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group. Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701 [Abstract] [Full Text] [Related]
4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910 [Abstract] [Full Text] [Related]
5. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S, Diabetes Control and Complications Trial, Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med; 2003 Jun 05; 348(23):2294-303. PubMed ID: 12788993 [Abstract] [Full Text] [Related]
6. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Diabetes; 2011 Feb 05; 60(2):582-9. PubMed ID: 20980456 [Abstract] [Full Text] [Related]
8. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort. Polak JF, Backlund JC, Budoff M, Raskin P, Bebu I, Lachin JM, DCCT/EDIC Research Group. J Am Heart Assoc; 2021 Dec 21; 10(24):e022922. PubMed ID: 34873921 [Abstract] [Full Text] [Related]
11. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G, Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group. Diabetes Care; 2008 Oct 21; 31(10):2006-12. PubMed ID: 18628568 [Abstract] [Full Text] [Related]
12. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Lachin JM, Orchard TJ, Nathan DM, DCCT/EDIC Research Group. Diabetes Care; 2014 Oct 21; 37(1):39-43. PubMed ID: 24356596 [Abstract] [Full Text] [Related]
18. [Ultrasonographic evaluation of selected parameters of the endothelial function in brachial arteries and IMT measurements in carotid arteries in children with diabetes type 1 using personal insulin pumps--preliminary report]. Tołwińska J, Głowińska-Olszewska B, Urban M, Florys B, Peczyńska J. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Feb 21; 12(3):200-4. PubMed ID: 17020656 [Abstract] [Full Text] [Related]